Cellcyte Genetics Corp (CCYG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 7 |
| Receivables | N/A | N/A | N/A | N/A | 26 |
| TOTAL | $9 | $9 | $9 | $10 | $40 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 7 | 15 | 138 |
| Intangibles | 0 | 16 | 24 | 31 | 39 |
| TOTAL | $N/A | $16 | $31 | $46 | $177 |
| Total Assets | $9 | $26 | $39 | $57 | $217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 126 | 73 | 597 | 663 | 645 |
| Accrued Expenses | 82 | 119 | 92 | 80 | 19 |
| Other current liabilities | 141 | 141 | 141 | 141 | 141 |
| TOTAL | $351 | $335 | $1,258 | $917 | $835 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 251 | 232 |
| Other Non-Current Liabilities | 478 | 346 | 23 | 23 | 22 |
| TOTAL | $478 | $346 | $23 | $274 | $254 |
| Total Liabilities | $829 | $681 | $1,281 | $1,190 | $1,089 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,329 | 82,329 | 82,329 | 74,556 | 72,338 |
| Common Shares | 82 | 82 | 82 | 75 | 71 |
| Retained earnings | -12,685 | -12,521 | -13,107 | -12,748 | -11,949 |
| Other shareholders' equity | 49 | 49 | 49 | 49 | 49 |
| TOTAL | $-820 | $-656 | $-1,242 | $-1,134 | $-872 |
| Total Liabilities And Equity | $9 | $26 | $39 | $57 | $217 |